Alpha Tau Medical (DRTS) Payables (2020 - 2026)
Alpha Tau Medical (DRTS) posted Payables of $3.7 million for Q1 2026, down 3.88% sequentially from $3.9 million in Q4 2025, and up 44.28% YoY from $2.6 million in Q1 2025.
Alpha Tau Medical (DRTS) Payables (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Payables for 7 years, with the latest figure at $3.7 million in Q1 2026.
- Quarterly Payables rose 44.28% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 44.28% YoY) and the FY2025 annual result came in at $3.9 million, up 9.54% from the prior year.
- Payables declined to $3.7 million in Q1 2026 per DRTS's latest filing, from $3.9 million in the prior quarter.
- Over five years, Payables peaked at $3.9 million in Q4 2025 and troughed at $1.2 million in Q2 2022.
- A 5-year average of $2.5 million and a median of $2.5 million in 2024 frame the typical range for Payables.
- The widest YoY moves for Payables: up 80.32% in 2023, down 45.99% in 2023.
- Over 5 years, Payables stood at $1.4 million in 2022, then jumped by 80.32% to $2.6 million in 2023, then jumped by 37.61% to $3.5 million in 2024, then climbed by 9.54% to $3.9 million in 2025, then dropped by 3.88% to $3.7 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $3.7 million, $3.9 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.17 Mn |
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | 3.87 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Dec 31, 2024 | 3.53 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 2.07 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 3.83 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Dec 31, 2020 | 964,000.00 |